inclusion criteria: - men and women aged 18 and over - can give informed consent - confirmed positive result for sars-cov-2 within 72 hours from the date the result was issued (according to the laboratory report) - patient presently symptomatic with one or more of the following symptoms: fever, cough, myalgia, mild dyspnoea, chest pain, diarrhea, nausea, vomiting, anosmia, lack of taste, sore throat, nasal congestion - at initial screening, the subject will report at least one and no more than 3 of the following risk factors for clinical worsening: age ≥40, obesity, hypertension, diabetes, pulmonary disease (e.g., asthma, copd), and immune disorders (e.g. rheumatoid arthritis, lupus), neurological diseases: e.g. after a distant stroke or trauma to the brain, multiple sclerosis, dementia and other neurodegenerative diseases) - patients hospitalized due to meeting the above criteria and requiring observation in a hospital or outpatient setting.

inclusion criteria: - men and women aged 18 and over - can give informed consent - confirmed positive result for sars-cov-2 within 72 hours from the date the result was issued (according to the laboratory report) - patient presently symptomatic with one or more of the following symptoms: fever, cough, myalgia, mild dyspnoea, chest pain, diarrhea, nausea, vomiting, anosmia, lack of taste, sore throat, nasal congestion - at initial screening, the subject will report at least one and no more than 3 of the following risk factors for clinical worsening: age ≥40, obesity, hypertension, diabetes, pulmonary disease (e.g., asthma, copd), and immune disorders (e.g. rheumatoid arthritis, lupus), neurological diseases: e.g. after a distant stroke or trauma to the brain, multiple sclerosis, dementia and other neurodegenerative diseases) - patients hospitalized due to meeting the above criteria and requiring observation in a hospital or outpatient setting.

inclusion criteria: - men and women aged 18 and over - can give informed consent - confirmed positive result for sars-cov-2 within 72 hours from the date the result was issued (according to the laboratory report) - patient presently symptomatic with one or more of the following symptoms: fever, cough, myalgia, mild dyspnoea, chest pain, diarrhea, nausea, vomiting, anosmia, lack of taste, sore throat, nasal congestion - at initial screening, the subject will report at least one and no more than 3 of the following risk factors for clinical worsening: age ≥40, obesity, hypertension, diabetes, pulmonary disease (e.g., asthma, copd), and immune disorders (e.g. rheumatoid arthritis, lupus), neurological diseases: e.g. after a distant stroke or trauma to the brain, multiple sclerosis, dementia and other neurodegenerative diseases) - patients hospitalized due to meeting the above criteria and requiring observation in a hospital setting.

inclusion criteria: - men and women aged 18 and over - can give informed consent - confirmed positive result for sars-cov-2 within 72 hours from the date the result was issued (according to the laboratory report) - patient presently symptomatic with one or more of the following symptoms: fever, cough, myalgia, mild dyspnoea, chest pain, diarrhea, nausea, vomiting, anosmia, lack of taste, sore throat, nasal congestion - at initial screening, the subject will report at least one and no more than 3 of the following risk factors for clinical worsening: age ≥40, obesity, hypertension, diabetes, pulmonary disease (e.g., asthma, copd), and immune disorders (e.g. rheumatoid arthritis, lupus), neurological diseases: e.g. after a distant stroke or trauma to the brain, multiple sclerosis, dementia and other neurodegenerative diseases) - patients hospitalized due to meeting the above criteria and requiring observation in a hospital setting.